Reply to Assoc. Prof. Kocak

Acta Oncol. 2022 Mar;61(3):320. doi: 10.1080/0284186X.2021.2023216. Epub 2022 Jan 11.

Linda Willén^{1

2

3}, Anders Berglund⁴, Stefan Bergström^{1

2

3}, Johan Isaksson^{1

5

6}, Michael Bergqvist², Gunnar Wagenius^{7

8}, Mats Lambe⁹

¹ Center for Research and Development, Uppsala University/Region Gävleborg, Gävle, Sweden.
² Department of Radiation Sciences and Oncology, Umeå University, Umeå, Sweden.
³ Department of Oncology, Gävle Hospital, Gävle, Sweden.
⁴ EpiStat, Uppsala, Sweden.
⁵ Department of Pulmonary Medicine, Gävle Hospital, Gävle, Sweden.
⁶ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁷ Division of Oncology, Department of Clinical Science Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
⁸ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁹ Regional Cancer Center Central Sweden, Uppsala, Sweden.

No abstract available

Publication types